People On The Move: Appointments At GSK, Karo And Lonza
The latest European consumer health industry appointments: GSK names Sheppard as DACH head; Karo hires GSK’s Hale as CMO; and Lonza brings in Novartis’ Deecke as CFO.
You may also be interested in...
EU Business Round-Up: Midsona Acquires Finland's Vitality, Karo Hires CCO From J&J, Navamedic Sees OTC Sales Rise
The latest European business news: Sweden's Midsona expands its consumer health offering by acquiring Finland's Vitality; Karo Pharma hires J&J exec as CCO; and Navamedic sees sales rise driven by OTC growth.
Private equity firms Bain Capital and Cinven Group Ltd. agree to acquire Lonza’s specialty ingredients business for $4.72Bn. Lonza says it will focus on its pharma, biotech and nutrition business, including a nutraceutical capsule manufacturing operation.
UK consumer healthcare industry association PAGB is preparing its response to a "wide ranging" consultation on the future of how medical devices are regulated in the country. MHRA says it wants a system that streamlines product approvals while still prioritizing patient safety.